Vinorelbine: all 238 studies that test it
Page 1 of 3. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in ChildrenNot yet recruitingNCT07137884Phase 2
- Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.Not yet recruitingNCT06857747Not applicable
- Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGSNot yet recruitingNCT06692491Phase 2
- LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic PatientsRecruitingNCT06576635Not applicable
- A Study of BV-AVD in People With Bulky Hodgkin LymphomaRecruitingNCT06377566Phase 2
- A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerRecruitingNCT05999994Phase 2
- Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast CancerRecruitingNCT05823623Phase 2
- Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast CancerRecruitingNCT05296577Phase 2
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)Not yet recruitingNCT04922008Phase 2
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaRecruitingNCT04625907Phase 1/2
- Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsRecruitingNCT04304352Phase 2
- European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsRecruitingNCT02813135Phase 1/2
- Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast CancerCompletedNCT03887130Phase 2Results posted
- Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid TumorsTerminatedNCT03386721Phase 2Results posted
- MEtronomic TrEatment Option in Advanced bReast cAncerCompletedNCT02954055Phase 2Results posted
- Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLCCompletedNCT02709720Phase 2Results posted
- Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast CancerTerminatedNCT02658084Phase 1/2Results posted
- A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerCompletedNCT01565083Phase 2Results posted
- Vinorelbine for Children With Progressive or Recurrent Low-grade GliomasCompletedNCT01497860Phase 2Results posted
- Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)CompletedNCT01443078Phase 2Results posted
- Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain MetastasesCompletedNCT01441596Phase 2Results posted
- A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain MetastasesCompletedNCT01305941Phase 2Results posted
- LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresCompletedNCT01271725Phase 2Results posted
- Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive StrategyCompletedNCT01209520Not applicableResults posted
- Trastuzumab and Vinorelbine in Advanced Breast CancerTerminatedNCT01185509Phase 2Results posted
- Lapatinib in Combination With VinorelbineCompletedNCT01128543Phase 2Results posted
- Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung CancerCompletedNCT01109524Phase 2Results posted
- Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin LymphomaCompletedNCT01026220Phase 3Results posted
- Lapatinib in Combination With VinorelbineCompletedNCT01013740Phase 2Results posted
- Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid TumorsCompletedNCT00958724Phase 1Results posted
- Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2CompletedNCT00906698Phase 1Results posted
- Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTerminatedNCT00863512Phase 3Results posted
- Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00842712Phase 2Results posted
- Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer SubjectsTerminatedNCT00709618Phase 2Results posted
- Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast CancerCompletedNCT00706030Phase 1/2Results posted
- Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast CancerCompletedNCT00670982Phase 2Results posted
- Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00602797Phase 2Results posted
- Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin LymphomaCompletedNCT00574496Phase 2Results posted
- Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung CancerTerminatedNCT00545948Phase 2Results posted
- Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver DysfunctionCompletedNCT00540982Phase 1/2Results posted
- Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)CompletedNCT00503750Phase 2Results posted
- Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLCCompletedNCT00499109Phase 3Results posted
- A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to BrainTerminatedNCT00476827Phase 2Results posted
- A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.CompletedNCT00432562Phase 1Results posted
- Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous TherapyCompletedNCT00381940Phase 2Results posted
- Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's LymphomaCompletedNCT00302003Phase 3Results posted
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00266110Phase 2Results posted
- Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant MelanomaCompletedNCT00256282Phase 2Results posted
- The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung CancerCompletedNCT00215930Phase 2Results posted
- Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTerminatedNCT00194792Phase 2Results posted
- Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
- Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerTerminatedNCT00176488Phase 2Results posted
- Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell FunctionTerminatedNCT00169104Phase 2/3Results posted
- Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)CompletedNCT00148798Phase 3Results posted
- Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast CancerCompletedNCT00148668Phase 2Results posted
- Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00093808Phase 2Results posted
- Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the CervixCompletedNCT00064077Phase 3Results posted
- Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II TrialTerminatedNCT00041470Phase 1/2Results posted
- S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00041067Phase 2Results posted
- Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain MetastasesCompletedNCT00026494Phase 1/2Results posted
- Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerActive, not recruitingNCT06632327Phase 3
- Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung CancerActive, not recruitingNCT06540950Phase 2
- Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort StudyActive, not recruitingNCT06451302Not applicable
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)Active, not recruitingNCT06382142Phase 3
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)Active, not recruitingNCT06343948Phase 3
- Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast CancerStatus unknownNCT05747326Phase 2
- Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)Status unknownNCT05603013Phase 2
- Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast CancerTerminatedNCT05583110Phase 2
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
- A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast CancerTerminatedNCT05134194Phase 3
- A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaActive, not recruitingNCT04994132Phase 3
- Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung CancerActive, not recruitingNCT04922658Phase 2
- Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerCompletedNCT04903652Phase 2
- Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant TherapyStatus unknownNCT04848454Phase 2
- Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast CancerActive, not recruitingNCT04759248Phase 2
- Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast CancerStatus unknownNCT04665986Phase 3
- Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast CancerStatus unknownNCT04605575Phase 2
- Evolutionary Therapy for RhabdomyosarcomaActive, not recruitingNCT04388839Phase 2
- NX in Luminal B Breast Cancer Patients After Neoadjuvant ChemotherapyStatus unknownNCT04307147Phase 3
- A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant ChemotherapyStatus unknownNCT04302441Phase 2
- Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaActive, not recruitingNCT04299113Phase 1
- Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)CompletedNCT04296162Phase 2
- Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast CancerStatus unknownNCT04143906Phase 2
- A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerStatus unknownNCT03997539Phase 2
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.Status unknownNCT03947242Not applicable
- A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast CancerStatus unknownNCT03933982Phase 2
- Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast CancerStatus unknownNCT03932526Phase 2
- A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast CancerWithdrawnNCT03811418Phase 3
- Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung CancerCompletedNCT03801304Phase 2
- Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt CoursesActive, not recruitingNCT03620032Phase 2
- Vinorelbine in Advanced BRAF-like Colon CancerCompletedNCT03482362Phase 2
- Vinorelbine for Recurrent ALCL-2017CompletedNCT03443128Phase 2
- The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage TherapyStatus unknownNCT03423849Phase 2/3
- The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialStatus unknownNCT03402048Phase 3
- Vinorelbine for Recurrent ACLCCompletedNCT03397953Phase 2
- Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)CompletedNCT03345810Phase 2
- Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant ChemotherapyStatus unknownNCT03270007Phase 4
- PemVin vs Vin in Previously Treated Metastatic Breast CancerCompletedNCT03242616Phase 2
- Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian CancerStatus unknownNCT03188159Phase 2
- Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell LymphomasCompletedNCT03161054Phase 2